Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • chinesehamsters chinesehamsters Aug 22, 2014 12:29 PM Flag

    Time to lighten up....

    The ADC technology this company has is one of the most impressive new developments in biotech than I have seen in years. Unfortunately it is in the hands of a bunch of embiciles that have been unable to ink a meaninful deal with anyone in the last couple of years. What looked like a very promising investment has turned into dead money for me. So its time to fold up the tent and move on for me. I may keep a few thousand shares, but I have allocated way to much into this one holding.

    Not only are these fools doing nothing to generate any new biz, but it also looks like we are starting to see significant pushback from reimbursement/insurance regulators also. To them, it does not matter what the drug can do for a patient if it costs more than they are willing to pay. For that reason, Kadcyla's growth may be limited. We are still a few years out from seeing the label expanded for Kadcyla as a result of the ongoing clinical trials. We cannot blame the current management for the royalty structure for Kadcyla, but that is also working against Immunogen as well. I sincerely hope that Immunogen get's aquired so that this ADC technology can truly be put to use and create some meaningful new drugs. Too bad you cannot sell covered calls in a 401K as I would use that to move out of this investment.

    Chinese Hamsters

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMGN
10.12+0.04(+0.40%)Apr 17 4:00 PMEDT